These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6333351)

  • 1. Human serum megakaryocyte colony-stimulating activity increases in response to intensive cytotoxic chemotherapy.
    Mazur EM; de Alarcón P; South K; Miceli L
    Exp Hematol; 1984 Sep; 12(8):624-8. PubMed ID: 6333351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human megakaryocyte colony-stimulating factor in sera from aplastic dogs: partial purification, characterization, and determination of hematopoietic cell lineage specificity.
    Mazur EM; South K
    Exp Hematol; 1985 Dec; 13(11):1164-72. PubMed ID: 3877646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies.
    Hoffman R; Mazur E; Bruno E; Floyd V
    N Engl J Med; 1981 Sep; 305(10):533-8. PubMed ID: 6973086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryocyte colony-stimulating factor (Mk-CSF): its physiologic significance.
    de Alarcon PA
    Blood Cells; 1989; 15(1):173-85. PubMed ID: 2649180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases.
    Roberts MM; Dyson PG; Willson K; Juttner CA; To LB
    Bone Marrow Transplant; 1996 Jul; 18(1):41-5. PubMed ID: 8831994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two antigenically different types of colony-stimulating activities in sera of patients with aplastic anemia.
    Ishizaka Y; Motoyoshi K; Shionoya S; Ikeda K; Hatake K; Saito M; Takaku F; Miura Y
    Exp Hematol; 1985 Aug; 13(7):591-6. PubMed ID: 3875495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early suppressive effects of chemotherapy on recovery of bone marrow megakaryocyte precursors: possible relationship to platelet recovery.
    Warren MK; Zujewski J; Rose WL; Szabo JM; O'Shaughnessy JA; Halverson DC; Cowan KH; Gress RE; Schwartz GN
    Stem Cells; 1996; 14 Suppl 1():31-7. PubMed ID: 11012200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of response of megakaryocyte colony-stimulating activity in the serum of patients undergoing bone marrow transplantation.
    de Alarcon PA; Schmieder JA; Gingrich R; Klugman MP
    Exp Hematol; 1988 May; 16(4):316-9. PubMed ID: 3282902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The inhibitory effects of serum of patients with acute promyelocytic leukemia on the formation of megakaryocytopoiesis colony unit].
    Zhou R; Sun G; Wu W
    Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):278-80. PubMed ID: 8758274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 5-fluorouracil on hematopoiesis: studies of murine megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
    Yeager AM; Levin J; Levin FC
    Exp Hematol; 1983 Nov; 11(10):944-52. PubMed ID: 6662215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
    Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
    Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human megakaryocytic colony formation in human plasma.
    Solberg LA; Jamal N; Messner HA
    J Cell Physiol; 1985 Jul; 124(1):67-74. PubMed ID: 4044652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
    Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of bone marrow regeneration following chemotherapy for acute myeloid leukemia.
    Islam A
    J Med; 1987; 18(2):108-22. PubMed ID: 3480927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin].
    Lemez P; Gáliková J; Haas T
    Vnitr Lek; 1999 Jun; 45(6):342-6. PubMed ID: 11045169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A; Olofsson T
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.